Ola Nived
101 – 107 of 107
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
Novel roles of complement in systemic lupus erythematosus - Hypothesis for a pathogenetic vicious circle
(
- Contribution to journal › Article
- 1999
-
Mark
Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus
(
- Contribution to journal › Article
- 1996
-
Mark
Selective antibody reactivity with peptides from human endogenous retroviruses and nonviral poly(amino acids) in patients with systemic lupus erythematosus
(
- Contribution to journal › Article
- 1995
-
Mark
Sharing of MHC haplotypes among patients with systemic lupus erythematosus from unrelated Caucasian multicase families: disease association with the extended haplotype [HLA-B8, SC01, DR17]
(
- Contribution to journal › Article
- 1994
-
Mark
Increased antiretroviral antibody reactivity in sera from a defined population of patients with systemic lupus erythematosus. Correlation with autoantibodies and clinical manifestations
(
- Contribution to journal › Article
- 1990
-
Mark
Smoking and inflammatory bowel disease: comparison with lupus erythematiosus. A case-control study
(
- Contribution to journal › Article
-
Mark
Does primary fibromyalgia exist?
(
- Contribution to journal › Article